
Scientists discover microplastics in SEMEN and female reproductive fluid – and warn they could spark an infertility crisis
Now, it turns out even our most intimate moments can't escape their blight.
Scientists have discovered microplastics are 'common' in both male and female reproductive fluids.
And they warned of the potential implications for reproduction, as egg and sperm quality could be impaired.
The team examined follicular fluid – found within the ovaries - from 29 women and the seminal fluid, found within semen, from 22 men.
Analysis revealed a range of commonly-used microplastics were present in more than half of the samples.
This included microplastics linked to non-stick coatings, polystyrene, plastic containers, wool, insulation and cushioning materials.
Lead researcher Dr Emilio Gomez-Sanchez, from the University of Murcia, said: 'Previous studies had already shown that microplastics can be found in various human organs.
'As a result, we weren't entirely surprised to find microplastics in fluids of the human reproductive system, but we were struck by how common they were – found in 69 per cent of the women and 55 per cent of the men we studied.'
Microplastics are defined as plastic particles under 5mm in size, and there is evidence that they pose a threat to environmental and public health.
While this research did not directly assess how microplastics affect fertility, their detection highlights the need to explore possible implications for human reproductive health, the researchers warned.
'What we know from animal studies is that in the tissues where microplastics accumulate, they can induce inflammation, free radical formation, DNA damage, cellular senescence, and endocrine disruptions,' Dr Gomez-Sanchez added.
'It's possible they could impair egg or sperm quality in humans, but we don't yet have enough evidence to confirm that.'
The scientists said the microplastics probably enter the body through ingestion, inhalation and contact with the skin.
From there they enter the bloodstream, which then distributes them throughout the body – including to the reproductive organs.
They plan to carry out further studies to explore the potential relationship between the presence of microplastics and egg and sperm quality.
The findings, published in the journal Human Reproduction, were presented at the annual meeting of the European Society of Human Reproduction and Embryology (ESHRE).
Commenting on the study Dr Carlos Calhaz-Jorge, Immediate Past Chair of ESHRE, said: 'Environmental factors influencing reproduction are certainly a reality, although not easy to measure objectively.
'The authors of this study found microplastics in over two-thirds of follicular fluids and more than 50 per cent of semen fluids from the studied patients.
'Although the significance of these findings is not yet clear, they should be considered an additional argument in favour of avoiding the generalised use of plastics in our daily lives.'
Previous studies have detected microplastics in human breast milk, blood and even brain tissue.
And separate research has found high levels in everyday items such as tea bags, baby bottles and chopping boards.
Some scientists have urged caution when interpreting the findings of the new study.
Dr Stephanie Wright, Associate Professor in Environmental Toxicology at Imperial College London, said: 'Without information on the sizes of the microplastic particles observed, it is challenging to interpret how meaningful this data is.
'There is a high potential for samples to become contaminated with microplastic throughout the sampling, laboratory processing, and analysis procedures.
'It is not a surprise that microplastics have been found – they are everywhere, even in the lab – but the data provided do not support that they are there as a result of human exposure as opposed to methodological artefact and must be interpreted with caution at this early stage.'
Fay Couceiro, Professor of Environmental Pollution and Head of the Microplastics Research Group at the University of Portsmouth, said: 'The study is very interesting and considering the global reduction in fertility rates, looking at possible causes is very topical and timely.
'As the authors state, finding microplastics is not that surprising as we have found them in lots of other areas of our bodies.
'Presence is also not the same as impact and the authors are clear that while they have found microplastics in the reproductive fluids of both men and women, we still don't know how they are affecting us.'
WHAT CAN MICROPLASTICS DO TO THE HUMAN BODY IF THEY END UP IN OUR FOOD SUPPLY?
According to an article published in the International Journal of Environmental Research and Public Health, our understanding of the potential human health effects from exposure to microplastics 'constitutes major knowledge gaps.'
Humans can be exposed to plastic particles via consumption of seafood and terrestrial food products, drinking water and via the air.
However, the level of human exposure, chronic toxic effect concentrations and underlying mechanisms by which microplastics elicit effects are still not well understood enough in order to make a full assessment of the risks to humans.
According to Rachel Adams, a senior lecturer in Biomedical Science at Cardiff Metropolitan University, ingesting microplastics could cause a number of potentially harmful effects, such as:
Inflammation: when inflammation occurs, the body's white blood cells and the substances they produce protect us from infection. This normally protective immune system can cause damage to tissues.
An immune response to anything recognised as 'foreign' to the body: immune responses such as these can cause damage to the body.
Becoming carriers for other toxins that enter the body: microplastics generally repel water and will bind to toxins that don't dissolve, so microplastics can bind to compounds containing toxic metals such as mercury, and organic pollutants such as some pesticides and chemicals called dioxins, which are known to causes cancer, as well as reproductive and developmental problems. If these microplastics enter the body, toxins can accumulate in fatty tissues.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
31 minutes ago
- The Independent
Climate change could bring tropical diseases to UK
Climate change is driving tropical infectious diseases like dengue and West Nile Virus northwards into Europe as pathogens thrive in hotter, more humid conditions, with fears the danger could spread to the UK. Researchers project a potential five-fold increase in chikungunya and dengue outbreaks by 2060, with 2024 dengue cases in Europe already surpassing the cumulative total of the previous 15 years. The spread is linked to the Asian tiger mosquito, a vector for dengue, chikungunya, and Zika, which is now established in several European countries including France, Germany, and Spain. Beyond vector-borne diseases, altered climate conditions, such as floods, also increase the risk of waterborne illnesses by disrupting water treatment and distribution. Experts recommend reducing greenhouse gas emissions, enhancing surveillance, controlling mosquito and tick populations, increasing vaccinations, and educating the public to manage these growing health threats.


The Independent
6 hours ago
- The Independent
Major microplastics finding raises fertility fears
Scientists have detected microplastic particles in human semen and female reproductive fluids for the first time. The new study, presented at ESHRE, found microplastics in nearly 70 percent of female follicular fluid samples and 55 percent of male semen samples. Common microplastic polymers, including PTFE, polystyrene, and polyethylene terephthalate, were identified in these reproductive fluids. This discovery raises concerns about potential risks to human health and fertility, building on previous research linking microplastics to inflammation, DNA damage, and hormone disruption. While direct impacts on fertility require further study, experts suggest reducing exposure by using glass containers and limiting water consumption from plastic bottles.


Daily Mail
7 hours ago
- Daily Mail
Now available - 'Viagra' spray that can trigger male arousal in just 10 minutes...would you try it?
A world-first oral spray that combats erectile dysfunction within roughly 10 minutes has launched in the UK, and costs £60. Called Hezkue, the liquid contains sildenafil, which is the same active ingredient in the iconic little blue pill, Viagra. However, because it is a liquid spray, clinical studies found it can work within as little as 12 minutes. Absorption can begin within five minutes of taking the spray, and on average it can trigger male arousal sufficient for sex within 25 minutes. It's a fraction of the time compared to the tablet forms of sildenafil which can take up to an hour to kick in. The pharmaceutical firm behind the product, Aspargo Labs Inc, say the product, which is sprayed into the mouth, also allows for dosage flexibility. The prescription-only medicine comes in two strengths; a recommended starting dose of 50mg, and a stronger solution of 100mg. Each 30ml bottle contains enough medicine for 24 doses, meaning that if the standard dosage of four 'pumps' is taken, it can last for six sex sessions. The product also been given the green light in Spain, Germany, Ireland and the Netherlands, and the company has applied for approval in the US. This means the spray has a price-per-use cost of £10. However, if the medicine has proved to be ineffective at the standard dose, clinicians may advise to try six pumps up to a maximum dose of eight. The manufacturers of Hezkue say that it is 'discrete and portable' as unlike tablets there is no need for a glass of water to take the product, and it is 'easy-to-carry'. It is exclusively available via a medical consultant prescribing it from the Pharmacy2U Online Doctor and Lloyds Pharmacy Online Doctor services. They are also looking to expand to Switzerland, other parts as the EU, as well as Latin America and the MENA regions, which includes the Middle East and North Africa. It is thought more than four million men in the UK suffer from ED, also known as impotence—which is when a man has difficulty getting or maintaining an erection. Sildenafil was first developed in the 1990s as a heart disease medication, but trial participants noticed it had an unusual side effect—frequent erections. In second place, was those aged between 16 and 24, with one in three experiencing over half of all sexual encounters. Despite popular belief, it isn't older men who experience erectile dysfunction the most, according to a recent study of 1,000 men by Click2Pharmacy. Less than half of men aged 55 or above struggled with impotence and less than one in five (18.2 per cent) experienced it more than half of the time, they found. Surprisingly, it was most common in young men, between the ages of 25 and 34, with three quarters having experienced it. Of the same age, 40 per cent experienced impotence during more than half of sexual encounters. In 2023 there were 4.57million NHS prescriptions in England for sildenafil, and other types of drugs. This was a new record level high, which experts said was likely due to due to tumbling drug prices and patients being less embarrassed to ask for help. NHS chiefs spent a total of £16.4million providing drugs to treat erectile dysfunction in 2023, about £3.60 per script, though pack sizes can vary. Even though there has been a record high number of prescriptions, the cost to the taxpayer was actually lower than that recorded in 2014. The condition isn't just all in men's heads—according to the British Association of Urological Surgeons, 90 per cent of cases stem from underlying physical issues. These experts found the most common underlying causes were heart disease (40 per cent), diabetes (33 per cent) and hormone problems (11 per cent). Other treatments to improve they highlighted were weight loss, increased exercise, and lifestyle change like drinking less alcohol. While most cases of erectile dysfunction are isolated and nothing to worry about, repeated or sustained impotency should be checked out by a GP. On the latest product, Michael S. Demurjian, Chairman and CEO of Aspargo Laboratories, Inc., said: 'It offers patients a new solution not seen in other available treatments, including traditional options such as pills, gels, injections, and strips.' Group Chief Medical Officer Kieran Seyan for Pharmacy2U and Lloyds Pharmacy Online Doctor added: 'We see first-hand how many people are seeking discreet, accessible ways to address their health concerns. Hezkue is an innovative alternative to traditional tablets.' In response to the new product release, Professor David Ralph, Urologist at University College London said: 'ED is a common and often distressing condition that can significantly impact a man's quality of life and emotional wellbeing. 'While effective treatments exist, barriers such as timing, convenience, and patient adherence can limit outcomes.